UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~June~~August 725, 2023

Veritas Farms, Inc.

(Exact name of registrant as specified in charter)

Nevada		333-210190		90-1254190
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

401 E. Las Olas Boulevard, Suite 1400 Fort Lauderdale, FL		33301
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (833) 691-4367

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

As used in this Current Report on Form 8-K, and unless otherwise indicated, the terms “the Company,” “Veritas,” “Veritas Farms,” “we,” “us” and “our” refer to Veritas Farms, Inc. and its subsidiary.

Item 1.01 Entry into a Material Definitive Agreement.

~~Credit~~Asset ~~Line~~Transfer Agreement

On ~~June~~August 725, 2023, ~~Veritas Farms, Inc. (~~the ~~“Company”)~~ ~~issued~~Company aacquired ~~secured~~substantially ~~convertible~~all ~~credit~~of ~~line promissory note in~~ the ~~principal~~assets ~~amount~~and ~~for~~business ~~up to $3,000,000~~ (the “~~2023~~Acquired ~~Secured Convertible Promissory Note~~Assets”), toof ~~the~~Asystem ~~Cornelis F~~Inc. ~~Wit Revocable Living Trust~~ (~~the~~ “~~Wit Trust~~Asystem”), ~~a principal shareholder who holds~~ ~~securities of the Company that constitute~~ a ~~majority~~Delaware ~~of the voting securities of the Company~~corporation. The ~~2023~~Acquired ~~Secured~~Assets ~~Convertible~~include ~~Promissory Note~~all ~~includes~~of ~~and~~Aystem’s ~~evidences~~rights ~~the outstanding indebtedness~~ in ~~the~~its ~~original~~science-forward ~~principal~~supplement ~~amount~~brand. ofThe ~~$1,750,000 of the Company to the Wit Trust~~Acquired ~~pursuant~~Assets towere ~~previously~~acquired ~~executed and delivered secured convertible promissory notes~~ by the Company ~~for~~under ~~the~~an ~~benefit~~Asset ofTransfer ~~the~~Agreement, ~~Wit~~dated ~~Trust~~August ~~pursuant to~~25, ~~the Amendment to Secured Convertible Promissory Notes described below. The~~ 2023, ~~Secured~~between ~~Convertible Promissory Note is secured by~~ the Company’s, ~~assets and contains certain covenants and customary events of default~~Asystem, ~~the~~Oliver ~~occurrence of which could result in an acceleration~~Walsh ~~of the 2023 Secured Convertible Promissory Note~~(“Mr. ~~The~~Walsh”),, ~~2023 Secured Convertible Promissory Note is convertible as follows: aggregate loaned principal~~ and ~~accrued~~Henry ~~interest~~Simonds ~~under~~(“Mr. ~~the~~Simonds”) ~~2023 Secured Convertible Promissory Note may, at~~ (the ~~option~~“Asset ofTransfer ~~the holder, be converted in its entirety into shares of our common stock at a conversion price of $0~~Agreement”).~~02 per~~ ~~share.~~Pursuant ~~The~~to ~~Note will accrue interest on~~ the ~~aggregate~~ ~~amount~~Asset ~~loaned~~Transfer atAgreement, aVeritas ~~rate~~acquired all of ~~10%~~Asystem’s ~~per~~customer ~~annum.~~lists, ~~All~~customers, ~~unpaid~~name, ~~principal~~trademarks, ~~together~~internet ~~with~~domains ~~any then unpaid~~ and ~~accrued interest and~~ other ~~amounts payable~~ ~~under~~things ~~the~~necessary ~~2023 Secured Convertible Promissory Note, is due and payable if not converted pursuant~~ to ~~the~~carry ~~terms and conditions of the 2023 Secured Convertible Promissory Note~~ on the ~~earlier~~business of ~~(i) October 01, 2026, or (ii) following an event of default~~Asystem.

The ~~foregoing~~consideration ~~summary~~for the Acquired Assets consisted of the ~~2023~~issuance ~~Secured~~of ~~Convertible Promissory~~103,570,600 ~~Note~~shares ~~does~~of ~~not~~Veritas ~~purport~~common tostock, bewhich ~~complete~~were distributed to Asystem shareholders, and isthe ~~qualified~~assumption inof ~~its~~certain ~~entirety~~liabilities of Asystem. The assumed liabilities included the assumption by ~~reference~~the Company of notes payable by Asystem with an aggregate outstanding balance of $250,000 that are payable to the ~~full~~Cornelis ~~text~~F. Wit Revocable Living Trust, of which Cornelis F. Wit is the ~~2023~~sole ~~Secured~~trustee ~~Convertible Promissory~~(“Wit ~~Note~~Trust”). ~~attached~~The ~~hereto~~notes ascarry ~~Exhibit~~an interest rate of ten percent (10.%) per annum and have a maturity date of April 1, 2024.

~~Amendment~~The toAsset ~~Previously~~Transfer ~~Issued~~Agreement also ~~and~~contained ~~Outstanding Promissory~~customary ~~Notes~~representations, warranties, indemnities, and covenants.

OnIn ~~June~~connection 7,with ~~2023,~~ the above-described ~~Company~~transaction, ~~and~~Veritas ~~the~~also ~~Wit Trust~~ entered into ana ~~Amendment~~consulting toagreement, ~~Secured~~dated ~~Convertible~~August ~~Promissory~~25, ~~Notes~~2023, ~~pursuant~~with toMr. ~~which~~Walsh the ~~Company~~Chairman ~~and~~of ~~the Wit Trust amended the following~~Asystem ~~seven previously executed secured convertible promissory notes held by the Wit Trust~~ (the “~~Amendment~~Walsh toConsulting ~~Secured Convertible Promissory Notes~~Agreement”):. ~~Secured~~The ~~Convertible~~Walsh ~~Promissory~~Consulting ~~Note~~Agreement ~~dated~~is ~~August~~for 2,an ~~2022~~initial interm ~~the original principal amount~~ of ~~$250,000,~~one ~~the~~year ~~Secured~~commencing ~~Convertible Promissory~~on ~~Note dated~~ August 17 25, ~~2022~~2023. inUnder the ~~original principal amount of $250~~agreement,~~000,~~ ~~the~~Mr. ~~Secured~~Walsh ~~Convertible~~received ~~Promissory~~an ~~Note~~award ~~dated September 6, 2022 in the original principal amount~~ of ~~$250~~11,~~000~~950,454 ~~the~~shares ~~Secured~~of ~~Convertible~~restricted ~~Promissory~~stock ~~Note~~pursuant ~~dated~~to ~~October 11, 2022 in~~ the ~~original~~terms ~~principal amount~~and conditions of ~~$250,000,~~ the ~~Secured~~Veritas ~~Convertible Promissory Note dated November 16~~Farms, ~~2022~~Inc. in2023 ~~the~~Equity ~~original~~Incentive ~~principal~~Plan ~~amount~~and ofsubject ~~$250,000,~~to the ~~Secured~~ ~~Convertible~~further ~~Promissory Note dated January 3~~terms, ~~2023~~conditions ~~in the original principal amount of $250,000,~~ and ~~the~~restrictions ~~Secured~~contained ~~Convertible Promissory Note dated May 30, 2023~~ in ~~the~~a ~~original principal amount of $250~~separate agreement,~~000,~~ ~~collectively~~titled ~~which~~“2023 ~~total~~Equity ~~the~~Incentive ~~aggregate~~Plan ~~outstanding~~Restricted ~~principal~~Stock ~~amount of~~Award ~~$1,750,000 (collectively the “Notes~~Agreement”). The ~~Amendment~~restrictions towill ~~Secured~~lapse ~~Convertible~~ratably ~~Promissory~~over one ~~Notes~~year ~~amended,~~on ~~replaced and superseded~~ the ~~Notes~~subsequent inanniversary ~~their~~of ~~entirety,~~the ~~and~~issuance ~~will~~date besubject ~~included~~to incontinuous ~~and~~service ~~part~~to of the ~~2023 Secured Convertible Promissory Note described above~~Company.

The ~~foregoing~~description ~~summary~~in this report of the ~~Amendment~~Asset toTransfer ~~Secured Convertible~~Agreement ~~Promissory~~and ~~Notes~~the Walsh Consulting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of ~~the~~such ~~Amendment to~~agreements ~~Secured Convertible Promissory Notes~~ attached hereto as Exhibit 10.1 and Exhibit 10.2, respectively, which are incorporated by reference herein.

1Changes in Management

~~Item~~Appointment ~~2.03 Creation~~ of aNew ~~Direct~~Directors ~~Financial~~and Executive ~~Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.~~Officers

~~The~~On ~~disclosure~~August ~~set~~25, ~~forth~~2023, ~~under~~Mr. ~~Item~~Simonds ~~1.01~~was elected and appointed to the board of ~~this~~directors ~~Current~~of ~~Report~~the onCompany. ~~Form~~In ~~8-K~~addition, ~~with~~Marisa ~~respect~~Cifre to(“Mrs. ~~the~~Cifre”) ~~issuance~~was appointed as Chief Revenue Officer of the ~~2023~~Company ~~Secured~~and ~~Convertible~~Thomas ~~Promissory~~J. ~~Note~~Krogh is(“Mr. ~~incorporated~~Krogh”) ~~herein by~~was ~~reference~~appointed as Chief Operating Officer of the Company.

~~Item~~The 3following is a brief description of the background and business experience of Mr.02 Simonds, Mrs. ~~Unregistered~~ ~~Sale~~Cifre ofand ~~Equity~~Mr. ~~Securities~~Krogh.

~~The~~Henry ~~disclosure~~Simonds, ~~set~~age ~~forth~~36, ~~under~~prior ~~Item~~to ~~1.01 of~~joining ~~this~~the ~~Current~~Company, ~~Report~~from onJune 2019 ~~Form~~to ~~8-K~~August ~~with~~2023, ~~respect~~Mr. toSimonds ~~the~~was ~~issuance~~President ofat ~~the~~Asystem, ~~2023~~Inc., ~~Secured~~a ~~Convertible~~science ~~Promissory~~forward ~~Note~~supplement isbrand ~~incorporated~~whose byassets ~~reference into~~were ~~this~~acquired ~~Item~~by Veritas Farms ~~3.02.~~in ~~The~~August 2023. From ~~Secured~~April ~~Convertible~~2017 ~~Promissory~~to ~~Note~~May ~~issued~~2019, toMr. ~~the~~Simonds ~~investor~~served ~~was~~as ~~offered~~Co-Founder and ~~sold~~advisor into Tyme Food, a ~~transaction~~plant-based ~~exempt~~food ~~from~~company ~~registration~~based ~~under~~in New York. Previously, Mr. Simonds was the ~~Securities~~Global ~~Act~~Head of ~~1933,~~Sustainability asat ~~amended,~~Saatchi in& ~~reliance~~Saatchi. onMr. ~~Section~~Simonds 4(holds a~~)(2)~~ B.A. ~~thereof~~degree in Geography from Leeds University.

~~Item~~Marisa 9Cifre, age 29, was named Chief Revenue Officer of Veritas Farms in August 2023, and has served as Vice President of Sales & Marketing from July 2022 to August 2023, and served in various marketing roles since joining the Company in September 2019.01 ~~Financial~~Prior ~~Statements~~to joining the Company, Mrs. Cifre held various roles, including Marketing Specialist, for CereScan and ~~Exhibits~~CereHealth, a biotech company that specializes in state-of-the-art functional brain imaging used in clinical studies and a predictive analytics platform used to diagnose brain injuries or disorders. Mrs. Cifre holds a Master of Science degree in Marketing & Analytics with a concentration in Brand Strategy and a Bachelor of Science in Business Administration degree in Marketing from the University of Denver.

~~(d) Exhibits~~1

Exhibit No		Description
10.1		Secured Convertible Credit Line Promissory Note dated June 7, 2023 by and between Veritas Farms, Inc. and the Cornelis F. Wit Revocable Living Trust
10.2		Amendment to Secured Convertible Promissory Notes dated June 7, 2023 by and between Veritas Farms, Inc. and the Cornelis F. Wit Revocable Living Trust
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

Thomas J. Krogh, age 32, was named Chief Operating Officer of Veritas Farms in August 2023, and has served as Vice President of Operations from July 2022 to August 2023, and previously served as Finance Manager since joining the Company in January 2020. Prior to joining the Company, Mr. Krogh held various roles, including Director of Finance for CBR International Corporation, a technical consulting group specializing in FDA representation, strategic program, process development & clinical program development for the biotechnology, pharmaceutical, and device industries worldwide. Mr. Krogh holds a Bachelor of Science in Business Administration degree in Finance from the University of Denver.

2On August 25, 2023, the Company entered into a consulting agreement with Mr. Simonds. The consulting agreement is for an initial term of one year commencing on that date of the agreement. Mr. Simonds will receive $4,167 monthly for his service, and an award of 4,233,485 shares of restricted stock pursuant to the terms and conditions of the Veritas Farms, Inc. 2023 Equity Incentive Plan and subject to the further terms, conditions and restrictions contained in a separate agreement, titled “2023 Equity Incentive Plan Restricted Stock Award Agreement”. The restrictions will lapse ratably over one year on the subsequent anniversary of the issuance date subject to continuous service to the Company.

~~SIGNATURES~~There are no family relationships between Mr. Simonds and any other director or executive officer of the Company. There are no understandings or arrangements between Mr. Simonds and any other person pursuant to which Mr. Simonds was appointed as a director of the Company. Mr. Simonds has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K promulgated under the Securities Act of 1933, as amended (“Securities Act”).

~~Pursuant~~Mr. toVickers ~~the~~a ~~requirements~~director of the ~~Securities~~Company since October ~~Exchange~~2020 ~~Act~~and as Chairman of ~~1934~~the Board since May 2021, ~~the~~Kuno ~~registrant~~D. ~~has~~van ~~duly~~der ~~caused~~Post ~~this~~a ~~report~~director toof bethe ~~signed~~Company onsince ~~its~~May ~~behalf~~2021 byand Gary A. Shangold a director of the ~~undersigned~~Company ~~hereunto~~since ~~duly~~December ~~authorized~~2022 will continue to serve in their respective roles.

Dated: June 13, 2023	VERITAS FARMS, INC.
	By:	/s/ Ramon A. Pino
		Ramon A. Pino, Chief Financial Officer

Mrs. Cifre’s service as Chief Revenue Officer will provide for an annual base salary of $120,000, subject to periodic review for increases, and an award of 500,000 shares of restricted stock pursuant to the terms and conditions of the Veritas Farms, Inc. 2023 Equity Incentive Plan and subject to the further terms, conditions and restrictions contained in a separate agreement, titled “2023 Equity Incentive Plan Restricted Stock Award Agreement”. The restrictions will lapse ratably over three years on the subsequent three anniversaries of the issuance date subject to continuous service to the Company. Mrs. Cifre will be eligible to participate in the standard employee benefit plans generally available to executive employees of the Company, including health insurance, life and disability insurance, 2023 Stock Incentive Plan, 401(k) plan, and paid time off and paid holidays. The Company will also reimburse Mrs. Cifre for her documented business expenses incurred in connection with her employment pursuant to the Company’s standard reimbursement expense policy and practices. Subject to the Board of Director’s determination, Mrs. Cifre will also be eligible to receive an incentive performance bonus based upon the Company’s performance with respect to applicable performance targets as determined by the Board of Directors.

3Mr. Krogh’s service as Chief Operating Officer will provide for an annual base salary of $120,000, subject to periodic review for increases, and an award of 500,000 shares of restricted stock pursuant to the terms and conditions of the Veritas Farms, Inc. 2023 Equity Incentive Plan and subject to the further terms, conditions and restrictions contained in a separate agreement, titled “2023 Equity Incentive Plan Restricted Stock Award Agreement”. The restrictions will lapse ratably over three years on the subsequent three anniversaries of the issuance date subject to continuous service to the Company. Mr. Krogh will be eligible to participate in the standard employee benefit plans generally available to executive employees of the Company, including health insurance, life and disability insurance, 2023 Stock Incentive Plan, 401(k) plan, and paid time off and paid holidays. The Company will also reimburse Mr. Krogh for his documented business expenses incurred in connection with his employment pursuant to the Company’s standard reimbursement expense policy and practices. Subject to the Board of Director’s determination, Mr. Krogh will also be eligible to receive an incentive performance bonus based upon the Company’s performance with respect to applicable performance targets as determined by the Board of Directors.

Mrs. Cifre and Mr. Krough are spouses, and Mrs. Cifre is the stepdaughter of Cornelis F. Wit, the trustee and grantor of the Cornelis F. Wit Revocable Living Trust, the largest stockholder of the Company. Otherwise, each of Mrs. Cifre and Mr. Krogh (a) has no family relationship with any director or other executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer, except that; and (b) is not a party to any related person transaction with the Company.

Director Independence

The Company’s Board of Directors has determined that each of our three non-employee, non-consultant directors, Mr. Vickers, Dr. van der Post and Dr. Shangold, are “independent” within the meaning of the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) and the listing standards of the Nasdaq Stock Market and the NYSE American. Moreover, our board of directors has determined that Mr. Vickers qualifies as an “audit committee financial expert” as the term is defined by the applicable rules and regulations of the SEC and the listing standards of the Nasdaq Stock Market and the NYSE American, based on his education and extensive financial and accounting experience as a principal financial officer, principal accounting officer and controller for 10 years.

Appointment of Committee Members

As of August 25, 2023, the following directors will serve as members of the following board committees:

Audit Committee:

Mr. Vickers, Chairman

Dr. Shangold

Compensation Committee:

Mr. Vickers, Chairman

Dr. van der Post

Nominating and Corporate Governance Committee:

Mr. Vickers, Chairman

Dr. van der Post

Dr. Shangold

Form of D&O Indemnification Agreement; Wit Indemnification Agreement

On August 30, 2023, the Company adopted a new form of Indemnification Agreement for directors and officers of the Company (the “D&O Indemnification Agreement”). The D&O Indemnification Agreement generally provides that the applicable director or executive officer will be indemnified by the Company to the maximum extent permitted by law, and will be entitled to advancement of defense costs, in connection with any event or occurrence relating to the fact that such person was an officer or director of the Company. The indemnification and other rights of an officer and director under such agreement are subject to customary covenants and limitations, including not having the right to indemnification for matters for which indemnification is not permitted by law.

On August 30, 2023, the Company entered into an Indemnification Agreement (the “Wit Indemnification Agreement”) with the Wit Trust. The Wit Indemnification Agreement provides that the Wit Trust will, from private funds, indemnify any director or executive officer of the Company from any claims or expenses relating to indemnifiable events (as defined in the D&O Indemnification Agreement) for which the Company is obligated to indemnify the director or executive officer but does not indemnify such officer or director. The obligations of the Wit Trust will survive for a period of two years after the date of the Wit Indemnification Agreement.

The foregoing descriptions in this report of the Wit Indemnification Agreement and D&O Indemnification Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements attached hereto as Exhibit 10.3 and Exhibit 10.4, respectively, which are incorporated by reference herein.

Item 2.01 Completion of Acquisition or Disposition of Assets.

The disclosure set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item 3.02 Unregistered Sale of Equity Securities.

The disclosure set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

into this Item 3.02. The shares issued to Asystem were offered and sold in a transaction exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(a)(2) thereof.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The disclosure set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On August 25, 2023, the stockholder holding a majority of the voting securities of the Company (the “Majority Stockholder”) of Company, took action by written consent (“Written Consent”) in accordance with Article 1, Section 7 of the Company’s by-laws and Sections 78.320 and 78,390 of the Nevada Revised Statutes. As of such date, the Majority Stockholder held approximately 4,548,401, or approximately 10.9% of the Company’s issued and outstanding common stock (“Common Stock”), 3,635,000 shares, or approximately 90.9% of the Company’s issued and outstanding Series A Convertible Preferred Stock (the “Series A Preferred Stock”), and 1,000,000 shares, or 100% of the Company’s issued and outstanding Series B Convertible Preferred Stock (the “Series B Preferred Stock”). The foregoing described shares of Common Stock, Series A Preferred Stock and Series B Preferred Stock held by the Majority Stockholder represented a majority of the votes entitled to be cast on the matters voted upon.

Pursuant to the Written Consent, and in lieu of the annual meeting of stockholders, the Majority Stockholder approved and re-elected all of the incumbent directors of the Company on the Board of Directors effective August 25, 2023.

Each incumbent director (a) has no family relationship with any other director or executive officer of the Company, and (b) is not a party to any related person transaction with the Company.

Item 7.01 Regulation FD Disclosure.

On August 28, 2023, the Company issued a press release announcing it having entered into the Asset Transfer Agreement. A copy of the press release is attached hereto as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information furnished pursuant to this Item 7.01, and including Exhibit 99.1 furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in this Current Report on Form 8-K or in any subsequent filing under the Exchange Act or any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(a)	Financial Statements of Business Acquired.

As permitted by Item 9.01(a)(4), the Company will, if required, file the financial statements required by Item 9.01(a)(1) of Form 8-K pursuant to an amendment to this Current Report on Form 8-K not later than 71 calendar days after the date this Current Report on Form 8-K must be filed.

(b)	Pro Forma Financial Information.

As permitted by Item 9.01(b)(2), the Company will, if required, file the pro forma financial information required by Item 9.01(b)(1) of Form 8-K pursuant to an amendment to this Current Report on Form 8-K not later than 71 calendar days after the date this Current Report on Form 8-K must be filed.

(d)

Exhibits.

The following exhibits are attached to this Current Report on Form 8-K:

Exhibit No		Description

10.1		Asset Transfer Agreement dated August 25, 2023
10.2		Consulting Agreement, dated August 25, 2023, between Veritas Farms, Inc. and Oliver Walsh
10.3		Indemnification Agreement dated August 30, 2023, between the Company and the Cornelis F. Wit Revocable Living Trust
10.4		Form of Indemnification Agreement for Directors and Officers
99.1*		Press Release dated August 28, 2023
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

*	Furnished but not filed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 31, 2023	VERITAS FARMS, INC.

	By:	/s/ Ramon A. Pino
		Ramon A. Pino, Chief Financial Officer

Filing Compare · Veritas Farms, Inc.